Benlysta Drug Interactions
Currently displaying a list of 246 drugs known to interact with Benlysta (belimumab).
- 44 major drug interactions
- 193 moderate drug interactions
- 9 minor drug interactions
Medications known to interact with Benlysta
Note: Showing generic names only.
- abatacept
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- ado-trastuzumab emtansine
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- ashwaganda
- atezolizumab
- avelumab
- axicabtagene ciloleucel
- azathioprine
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- belantamab mafodotin
- bevacizumab
- bifidobacterium infantis
- bifidobacterium longum
- bimekizumab
- blinatumomab
- bortezomib
- brentuximab
- brewer's yeast
- brexucabtagene autoleucel
- brodalumab
- canakinumab
- candida albicans extract
- carfilzomib
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cladribine
- coccidioidin skin test
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crovalimab
- daclizumab
- daratumumab
- dengue vaccine
- denosumab
- deucravacitinib
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- dostarlimab
- durvalumab
- echinacea
- eculizumab
- efalizumab
- efgartigimod alfa
- elderberry
- elotuzumab
- elranatamab
- emapalumab
- enfortumab vedotin
- epcoritamab
- etanercept
- etrasimod
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- ibritumomab
- ibrutinib
- idecabtagene vicleucel
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- interferon beta-1a
- interferon beta-1b
- interferon gamma-1b
- iodine i 131 tositumomab
- ipilimumab
- isatuximab
- ixazomib
- ixekizumab
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- lifileucel
- lisocabtagene maraleucel
- loncastuximab tesirine
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- monomethyl fumarate
- mosunetuzumab
- moxetumomab pasudotox
- mumps skin test antigen
- mumps virus vaccine
- pembrolizumab
- penpulimab
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- pozelimab
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ravulizumab
- retifanlimab
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib topical
- saccharomyces boulardii lyo
- sacituzumab govitecan
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) nvx-cov2705 vaccine, adjuvanted
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- siltuximab
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- spesolimab
- staphage lysate (spl)
- streptococcus salivarius
- sutimlimab
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- teclistamab
- teplizumab
- teriflunomide
- tetanus toxoid
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- toripalimab
- tositumomab
- trastuzumab
- tremelimumab
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
- zanubrutinib
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- ziv-aflibercept
- zoster vaccine live
- zoster vaccine, recombinant
Benlysta disease interactions
There are 3 disease interactions with Benlysta (belimumab) which include:
More about Benlysta (belimumab)
- Benlysta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (63)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lupkynis
Lupkynis is used to treat active lupus nephritis in adults with SLE. Lupkynis for lupus is a ...
Plaquenil
Plaquenil is used to treat or prevent malaria and to treat the symptoms of rheumatoid arthritis ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Sterapred
Sterapred is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Voclosporin
Voclosporin (brand name Lupkynis) is used to treat active lupus nephritis in adults with SLE ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Azathioprine
Azathioprine systemic is used for atopic dermatitis, autoimmune hepatitis, behcet's disease ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.